Simultaneous distinct cutaneous fungal infections with chromoblastomycosis due to Exophiala xenobiotica and hyalohyphomycosis due to Scedosporium apiospermum in a patient with severe cellular immunodeficiency.
cellular immunity
chromoblastomycosis
hyalohyphomycosis
interferon‐gamma
lymphocyte transformation test
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
05 Aug 2024
05 Aug 2024
Historique:
revised:
06
07
2024
received:
15
03
2024
accepted:
20
07
2024
medline:
5
8
2024
pubmed:
5
8
2024
entrez:
5
8
2024
Statut:
aheadofprint
Résumé
Deep-seated dermatomycosis is a rare disease that is often caused by trauma and/or systemic immunodeficiency. We describe a case of chromoblastomycosis complicated by hyalohyphomycosis that occurred simultaneously at different sites. A 92-year-old Japanese man who had been taking oral prednisolone for an IgG4-related respiratory disease visited our clinic. He developed brownish plaques with grayish-white scales with pseudo-carcinomatous hyperplasia and numerous brownish muriform cells developing in the dermis of his right hand, and multiple painful abscesses with pustules and papules and numerous hyphae within and around the histiocytes in the dermis of his right lower leg. Upon skin tissue culture and DNA sequencing, Exophiala xenobiotica and Scedosporium apiospermum were detected separately. He had severe cellular immunodeficiency indicated by low levels in the phytohemagglutinin (PHA)-stimulated lymphocyte transformation test (LTT) and serum interferon-gamma (IFN-γ), although his humoral immunity was normal. The patient died of bacterial pneumonia, despite antifungal drug treatment for 2 months. IFN-γ producing type 1 T helper (Th1) cells play an important role in the defense against fungal infections, however, corticosteroids specifically suppress Th1 cell responses and promote the induction of fungal infection. Measurement of PHA-stimulated LTT and serum IFN-γ may be useful in determining the severity and prognosis of deep-seated dermatomycosis in patients undergoing corticosteroid treatment.
Identifiants
pubmed: 39101398
doi: 10.1111/1346-8138.17412
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Kawasaki Medical School
ID : R05B-048
Informations de copyright
© 2024 Japanese Dermatological Association.
Références
Mochizuki T, Tsuboi R, Iozumi K, Ishizaki S, Ushigami T, Ogawa Y, et al. Guidelines for the management of dermatomycosis (2019). J Dermatol. 2020;47:1343–1373.
Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect. 2014;20(Suppl 3):47–75.
Queiroz‐Telles F, de Hoog S, Santos DW, Salgado CG, Vicente VA, Bonifaz A, et al. Chromoblastomycosis. Clin Microbiol Rev. 2017;30:233–276.
Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20(Suppl 3):27–46.
DeSimone MS, Crothers JW, Solomon IH, Laga AC. Scedosporium and Lomentospora infections are infrequent, difficult to diagnose by histology, and highly virulent. Am J Clin Pathol. 2021;156:1044–1057.
de Sousa M d GT, Ghosn EEB, Almeida SR. Absence of CD4+ T cells impairs host defence of mice infected with Fonsecaea pedrosoi. Scand J Immunol. 2006;64:595–600.
Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ. Host immune response against Scedosporium species. Med Mycol. 2009;47:433–440.
Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003;362:1828–1838.
Taves MD, Ashwell JD. Glucocorticoids in T cell development, differentiation and function. Nat Rev Immunol. 2021;21:233–243.
Passero LFD, Cavallone IN, Belda W Jr. Reviewing the etiologic agents, microbe‐host relationship, immune response, diagnosis, and treatment in Chromoblastomycosis. J Immunol Res. 2021;2021:9742832.
Sachs B, Fatangare A, Sickmann A, Glässner A. Lymphocyte transformation test: history and current approaches. J Immunol Methods. 2021;493:113036.
Leung JC, Lai CK, Chui YL, Ho RT, Chan CH, Lai KN. Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin. Clin Exp Immunol. 1992;90:147–153.
Jenks JD, Rawlings SA, Garcia‐Vidal C, Koehler P, Mercier T, Prattes J, et al. Immune parameters for diagnosis and treatment monitoring in invasive Mold infection. J Fungi (Basel). 2019;5:116.